Nifedipine Teva (Nifedipine)

Nifedipine blocks L‑type calcium channels on vascular smooth‑muscle cells, preventing calcium entry that is required for muscle contraction. This results in vasodilation of peripheral arteries, decreased systemic vascular resistance, and reduced workload on the heart, helping to control blood pressure and alleviate angina.

The appropriate dose of Nifedipine Teva is determined by the prescribing healthcare professional based on the patient’s medical condition, response to therapy, and other individual factors. Dosage adjustments are made according to clinical judgment and monitoring.

Safety data for Nifedipine Teva in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Nifedipine belongs to the dihydropyridine calcium‑channel blocker class, which primarily causes arterial vasodilation. Compared with beta‑blockers or ACE inhibitors, it has a rapid onset of vasodilatory effect and may be preferred when a strong peripheral arterial relaxation is needed, but individual therapy should be tailored to the patient’s overall profile.

Nifedipine Teva should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid environments such as bathrooms.

Nifedipine Teva is taken orally, usually with a glass of water. The tablet should be swallowed whole and not chewed or crushed unless specifically instructed by a healthcare professional. Dosing times and frequency are set by the prescriber.

Serious risks include severe hypotension, myocardial infarction, life‑threatening arrhythmias, and rare severe skin reactions such as Stevens‑Johnson syndrome. Patients should be monitored for sudden drops in blood pressure, chest pain, or any signs of allergic reaction, and seek immediate medical attention if they occur.

Nifedipine Teva is contraindicated in patients with known hypersensitivity to nifedipine or any component of the formulation, and in those with severe aortic stenosis or cardiogenic shock. Caution is also advised for individuals with significant liver disease, uncontrolled heart failure, or those taking interacting medications listed under major interactions.